{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:42:16Z","timestamp":1778337736920,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM 24211"],"award-info":[{"award-number":["GM 24211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.contraception.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T02:18:53Z","timestamp":1471313933000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clarification of contraceptive drug pharmacokinetics in obesity"],"prefix":"10.1016","volume":"95","author":[{"given":"William J.","family":"Jusko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.08.003_bb0005","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.contraception.2016.08.003_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2015.07.016","article-title":"Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis","volume":"92","author":"Yamazaki","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e31828317cc","article-title":"Contraceptive failures in overweight and obese combined hormonal contraceptive users","volume":"121","author":"McNicholas","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0889-8529(05)70362-5","article-title":"The endocrinology of obesity","volume":"25","author":"Smith","year":"1996","journal-title":"Endocrinol Metab Clin"},{"key":"10.1016\/j.contraception.2016.08.003_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ijo.2012.9","article-title":"Adiposity and sex hormones across the menstrual cycle: the BioCycle study","volume":"37","author":"Yeung","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.contraception.2016.08.003_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2016.08.003_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/clpt.1991.64","article-title":"Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity","volume":"50","author":"Dunn","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.08.003_bb0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2016.08.003_bb0045","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal weight women","volume":"81","author":"Westoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/2071301a0","article-title":"Blood levels of drug at the equilibrium state after multiple dosing","volume":"207","author":"Wagner","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.contraception.2016.08.003_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/clpt.1988.7","article-title":"Pharmacokinetics of single and multiple doses of ethinylestradiol and levonorgestrel in relation to smoking","volume":"43","author":"Kanarkowski","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.08.003_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.contraception.2010.05.001","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and three normal-weight women","volume":"82","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jps.2600720843","article-title":"Computation of model-independent pharmacokinetic parameters during multiple dosing","volume":"72","author":"Bauer","year":"1983","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.contraception.2016.08.003_bb0075","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jps.2600610820","article-title":"Effects of change in elimination on various parameters of the two-compartment open model","volume":"61","author":"Jusko","year":"1972","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.contraception.2016.08.003_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","article-title":"Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms and altered pharmacokinetic profile in obese oral contraceptive users","volume":"87","author":"Edelman","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity. A randomized controlled trial","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2010.04.016","article-title":"Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review","volume":"82","author":"Edelman","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00044011-200626120-00002","article-title":"Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug: as shown by once-daily divalproex-ER","volume":"26","author":"Dutta","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s11095-008-9787-9","article-title":"The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms","volume":"25","author":"Sahin","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.contraception.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0010-7824(92)90149-N","article-title":"Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive","volume":"46","author":"Kuhnz","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0010-7824(94)90014-0","volume":"50","author":"Kuhnz","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0115","series-title":"Effects of obesity on pharmacokinetics of the levonorgestrel emergency contraceptive pill, ClinicalTrials.Gov, NCT02104609","author":"Natavio","year":"2015"},{"key":"10.1016\/j.contraception.2016.08.003_bb0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2016.08.003_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/dmd.109.029249","article-title":"Xenobiotic-metabolizing cytochromes P450 in human white adipose tissue: expression and induction","volume":"38","author":"Ellero","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.contraception.2016.08.003_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"Edelman","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0010-7824(87)90024-2","article-title":"Plasma levels of levonorgestrel and free levonorgestrel index in women using Norplant implants or two covered rods (Norplant-2)","volume":"35","author":"Olsson","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11598930-000000000-00000","article-title":"The relationship between drug clearance and body size","volume":"51","author":"McLeay","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2016.08.003_bb0160","doi-asserted-by":"crossref","first-page":"110.e1","DOI":"10.1016\/j.ajog.2012.05.002","article-title":"Pharmacokinetics of the etonogestrel contraceptive implant in obese women","volume":"207","author":"Mornar","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.contraception.2012.08.042","article-title":"Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel","volume":"87","author":"Foegh","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2012.01.015","article-title":"Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system","volume":"86","author":"Seeber","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2009.01.004","article-title":"Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system","volume":"80","author":"Hidalgo","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0180","series-title":"Clinical Pharmacology Review, Liletta","author":"Food & Drug Administration","year":"2014"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.08.003_bb0185","first-page":"845","article-title":"Levonorgestrel levels in nonobese and obese women using LNG20, a new intrauterine contraceptive","author":"Creinin","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0190","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0195","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1210\/edrv-10-3-232","article-title":"The free hormone hypothesis: a physiologically based mathematical model","volume":"16","author":"Mendel","year":"1989","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2016.08.003_bb0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.contraception.2016.03.010","article-title":"The elusive minimum threshold concentration for contraceptive efficacy","volume":"94","author":"Cherala","year":"2016","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.contraception.2016.08.003_bb0205","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.contraception.2016.08.003_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0960-0760(99)00070-9","article-title":"Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane","volume":"69","author":"Rosner","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2009.08.009","article-title":"Interactions of sex hormone binding globulin with target cells","volume":"316","author":"Rosner","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cell.2005.06.032","article-title":"Role of endocytosis in cellular uptake of sex steroids","volume":"122","author":"Hammes","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.contraception.2016.08.003_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2009.07.021","article-title":"Cellular uptake of steroid carrier proteins \u2014 mechanisms and implications","volume":"316","author":"Willnow","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2016.08.003_bb0230","series-title":"Guidance for industry. Drug interaction studies \u2014 study design, data analysis, implications for dosing, and labeling recommendations","author":"Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.contraception.2016.08.003_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.contraception.2016.07.019","article-title":"Perspectives on variability in pharmacokinetics of an oral contraceptive product","volume":"95","author":"Jusko","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.08.003_bb0240","series-title":"ADAPT 5 user's guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"D'Argenio","year":"2009"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416303596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416303596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T04:24:40Z","timestamp":1542342280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416303596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0010782416303596"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.08.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clarification of contraceptive drug pharmacokinetics in obesity","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}